How homeodomain proteins find the right genes
Mechanisms of Homeodomain Transcription Factor Specificity
Researchers are figuring out how a large family of human gene-regulating proteins called homeodomain factors bind specific DNA sites so people with related genetic changes can get clearer answers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11370261 on NIH RePORTER |
What this research studies
I read that the team will use biochemical experiments, structural analyses, cell-based tests, and computer-based methods to see how homeodomain proteins with similar DNA-binding parts choose different targets. They will examine many human genetic variants linked to disease to determine how each change alters DNA binding and protein function. The project combines lab measurements with genomic and computational data to predict which variants are likely harmful. Ultimately their results aim to reduce the number of 'variants of unknown significance' for these genes.
Who could benefit from this research
Good fit: People with known or suspected genetic variants in homeodomain-containing genes or families affected by developmental disorders tied to these genes are most likely to benefit from the findings or future related studies.
Not a fit: Patients whose conditions are unrelated to homeodomain gene function or who do not have variants in these genes are unlikely to see direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could help turn unclear genetic findings in homeodomain genes into clearer diagnoses and priorities for follow-up care or therapy development.
How similar studies have performed: Previous biochemical and structural work has explained DNA binding for some homeodomain proteins and shown that some variants change binding, but applying these approaches broadly to hundreds of human variants is relatively new.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Gebelein, Brian — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Gebelein, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.